Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Unknown Primary

Clinical trial condition

Neoplasms, Unknown Primary

Explore clinical trials studying Neoplasms, Unknown Primary. Study availability and eligibility vary by location and protocol.

74 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Unknown Primary trial results

Completed

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

NCT00193609

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +3 more
Locations: Integrated Community Oncology Network Jacksonville, Florida, United States

AP&S Oncology & Hematology Northside Terre Haute, Indiana, United States

Greenview Regional Hospital Bowling Green, Kentucky, United States

Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States

View Trial Details

Completed

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

NCT00014456

Conditions: AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +100 more
Locations: Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

NCT00002507

Conditions: Carcinoma, Carcinoma of Unknown Primary, Carcinoma, Squamous Cell, +12 more
Locations: Yale Comprehensive Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

NCT00004922

Conditions: Adenocarcinoma, Carcinoma, Carcinoma of Unknown Primary, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

NCT00193596

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +3 more
Locations: Northeast Alabama Regional Medical Center Anniston, Alabama, United States

Clearview Cancer Institute Huntsville, Alabama, United States

Southern Cancer Center, Sacred Heart Heath System Medical Oncology Group Mobile, Alabama, United States

Northeast Arkansas Clinic Jonesboro, Arkansas, United States

View all 31 locations

View Trial Details

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

NCT00003943

Conditions: Carcinoma of Unknown Primary, Lung Cancer, Lung Diseases, +11 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

NCT01202786

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +3 more
Locations: Ha'emek Medical Center Afula, Israel

Soroka Medical Center Beersheba, Israel

Rabin Medical Center Petah Tikva, Israel

View Trial Details

Completed

Gemox as First and Second Line Therapy in Unknown Primary Cancer

NCT00353145

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +4 more
Locations: U.T. M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details